Prevention of Venous Thromboembolism in the Plastic Surgery Patient

被引：121

作者：

Davison, Steven Paul ^{[1
]}

Venturi, Mark L. ^{[1
]}

Attinger, Christopher E. ^{[1
]}

Baker, Stephen B. ^{[1
]}

Spear, Scott L. ^{[1
]}

机构：

[1] Georgetown Univ, Med Ctr, Div Plast Surg, Washington, DC 20007 USA

来源：

PLASTIC AND RECONSTRUCTIVE SURGERY | 2004年 / 114卷 / 03期

关键词：

D O I：

10.1097/01.PRS.0000131276.48992.EE

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Learning Objectives: After studying this article, the participant should be able to: 1. Identify the risk factors associated with venous thromboembolism. 2. Categorize a patient's individual risk as low, moderate, high, or highest. 3. Understand the available medications and devices that prevent venous thromboembolism. 4. Have a working algorithm of the appropriate prophylaxis options for each risk group.

引用

页码：43E / 51E

页数：9

共 27 条

[11] ABDOMINOPLASTY COMBINED WITH OTHER MAJOR SURGICAL-PROCEDURES - SAFE OR SORRY [J].

HESTER, TR ;

BAIRD, W ;

BOSTWICK, J ;

NAHAI, F ;

CUKIC, J .

PLASTIC AND RECONSTRUCTIVE SURGERY, 1989, 83 (06) :997-1004

[12] Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients -: A double-blind, randomized comparison [J].

Hull, RD ;

Pineo, GF ;

Francis, C ;

Bergqvist, D ;

Fellenius, C ;

Soderberg, K ;

Holmqvist, A ;

Mant, M ;

Dear, R ;

Baylis, B ;

Mah, A ;

Brant, R .

ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (14) :2199-2207

[13] Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients -: A double-blind, randomized comparison [J].

Hull, RD ;

Pineo, GF ;

Francis, C ;

Bergqvist, D ;

Fellenius, C ;

Soderberg, K ;

Holmqvist, A ;

Mant, M ;

Dear, R ;

Baylis, B ;

Mah, A ;

Brant, R .

ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (14) :2208-2215

[14] Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement [J].

Hull, RD ;

Brant, RF ;

Pineo, GF ;

Stein, PD ;

Raskob, GE ;

Valentine, KA .

ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (02) :137-141

[15] LOW-MOLECULAR-WEIGHT VERSUS STANDARD HEPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM AFTER MAJOR ABDOMINAL-SURGERY [J].

KAKKAR, VV ;

COHEN, AT ;

EDMONSON, RA ;

PHILLIPS, MJ ;

COOPER, DJ ;

DAS, SK ;

MAHER, KT ;

SANDERSON, RM ;

WARD, VP ;

KAKKAR, S .

LANCET, 1993, 341 (8840) :259-265

[16]

KEARSON C, 1994, PHARMACOL REV, V46, P89

[17] Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: Update of previous meta-analyses [J].

Koch, A ;

Bouges, S ;

Ziegler, S ;

Dinkel, H ;

Daures, JP ;

Victor, N .

BRITISH JOURNAL OF SURGERY, 1997, 84 (06) :750-759

[18] Generics and pulmonary medicine - 4 - Pulmonary embolism [J].

Laffan, M .

THORAX, 1998, 53 (08) :698-702

[19] LOW-MOLECULAR-WEIGHT HEPARIN VERSUS STANDARD HEPARIN IN GENERAL AND ORTHOPEDIC-SURGERY - A METAANALYSIS [J].

NURMOHAMED, MT ;

ROSENDAAL, FR ;

BULLER, HR ;

DEKKER, E ;

HOMMES, DW ;

VANDENBROUCKE, JP ;

BRIET, E .

LANCET, 1992, 340 (8812) :152-156

[20] Comparison of two low-molecular-weight heparins for the prevention of postoperative venous thromboembolism after elective hip surgery [J].

Planès, A ;

Vochelle, N ;

Fagola, M ;

Bellaud, M .

BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (06) :499-505

← 1 2 3 →